IceCure Medical R&D Spending Growth & History (ICCM)

IceCure Medical's r&d spending was $7.4M for fiscal 2025.

View full IceCure Medical company overview

IceCure Medical annual r&d spending history

IceCure Medical annual r&d spending

Fiscal yearPeriod endedR&D spendingChangeGrowth
20252025-12-31$7.4M$337,000+4.75%
20242024-12-31$7.1M−$1.2M−14.23%
20232023-12-31$8.3M−$850,000−9.32%
20222022-12-31$9.1M$3.2M+55.23%
20212021-12-31$5.9M$2.1M+54.29%
20202020-12-31$3.8M$808,000+26.92%
20192019-12-31$3.0M

IceCure Medical r&d spending trends

Over the last five fiscal years, IceCure Medical's r&d spending increased from $3.8M to $7.4M, a change of $3.6M. The latest reported quarter, Q2 2026, shows $2.1M.

About the metric

What research and development spending means

Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.

Calculation and source

SEC-reported R&D expense

TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review IceCure Medical source filings ↗

Community posts

It’s quiet here.

No posts about ICCM yet. Start the conversation.

Write the first post